Syros Pharmaceuticals (SYRS)

• Market cap: $59M
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 68

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

747% more call options, than puts

Call options by funds: $144K | Put options by funds: $17K

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

4.23% less ownership

Funds ownership: 80.48% [Q1] → 76.25% (-4.23%) [Q2]

6% less capital invested

Capital invested by funds: $112M [Q1] → $105M (-$6.81M) [Q2]

7% less funds holding

Funds holding: 75 [Q1] → 70 (-5) [Q2]

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4 82% upside
• Avg. target: $7.50 241% upside
• High target: $15 582% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Piper Sandler Edward Tenthoff 34% 1-year accuracy 13 / 38 met price target	127% upside $5	Overweight Reiterated	13 Aug 2024
JMP Securities Jason Butler 60% 1-year accuracy 18 / 30 met price target	82% upside $4	Market Outperform Maintained	13 Aug 2024
HC Wainwright & Co. Andrew Fein 49% 1-year accuracy 62 / 126 met price target	173% upside $6	Buy Maintained	13 Aug 2024
HC Wainwright & Co. Andrew Fein 49% 1-year accuracy 62 / 126 met price target	582% upside $15	Buy Reiterated	1 Aug 2024